OptimizeRx To Acquire Digital Therapeutics SaaS Platform Provider Organization, RMDY Health

OptimizeRx Corporation announced the acquisition of RMDY Health, a multipurpose digital therapeutics SaaS platform, for $16 million in cash and equity. The RMDY Health platform is used by pharmaceutical companies, payers, MedTech companies, and medical associations nationwide. The acquisition adds three new client segments to OptimizeRx’s existing consumer engagement platform – payers, medtech, and medical associations – further simplifying chronic disease management and drug adherence for healthier results at lower costs.

OptimizeRx is a recognized leader in bridging the communication gap between pharmaceutical companies and provider organizations with its digital health messaging platform delivered through its nationwide network of leading electronic . . .